Literature DB >> 4009821

The radiation sensitivities of R3327-H and R3327-AT rat prostate adenocarcinomas.

C Thorndyke, B E Meeker, G Thomas, W H Lakey, M S McPhee, J D Chapman.   

Abstract

Dunning R3327-H and R3327-AT tumors growing subcutaneously in the flanks of Fischer X Copenhagen rats were irradiated with 137Cs gamma-rays at volumes of approximately 300 mm. The effects of various doses of radiation were estimated by measurements of subsequent tumor growth as well as by histological evaluation. The well-differentiated, hormonally-responsive R3327-H tumor was more radiosensitive than the anaplastic R3327-AT tumor. The reasons for this increased radiation sensitivity of the R3327-H tumor include a greater "apparent" radiation sensitivity of tumor cells and the absence of tumor hypoxia. The presence of hypoxic tumor stem cells was inferred from significant radiosensitization of tumor growth delay by 0.5 mg./gm. misonidazole and by a technique which utilizes radioactively-labelled misonidazole as a marker for hypoxic cells. The persistence of a mass of R3327-H tumor tissue after aggressive radiotherapy was not indicative of tumor cells. Furthermore, the rapid increase in volume of R3327-AT cells after aggressive radiotherapy was attributed to limited proliferation of tumor cells which were destined to ultimately die. Possible implications of these findings for the management of human prostatic adenocarcinoma are discussed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4009821     DOI: 10.1016/s0022-5347(17)47055-8

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  10 in total

1.  A study of the relationship of metabolic MR parameters to estrogen dependence in breast cancer xenografts.

Authors:  Ting Liu; Kavindra Nath; Weixia Liu; Rong Zhou; I-Wei Chen
Journal:  NMR Biomed       Date:  2015-07-14       Impact factor: 4.044

2.  Lactate MRSI and DCE MRI as surrogate markers of prostate tumor aggressiveness.

Authors:  J Yaligar; S B Thakur; L Bokacheva; S Carlin; H T Thaler; A Rizwan; M E Lupu; Y Wang; C C Matei; K L Zakian; J A Koutcher
Journal:  NMR Biomed       Date:  2011-05-25       Impact factor: 4.044

3.  Tumor oxygen dynamics: correlation of in vivo MRI with histological findings.

Authors:  Dawen Zhao; Sophia Ran; Anca Constantinescu; Eric W Hahn; Ralph P Mason
Journal:  Neoplasia       Date:  2003 Jul-Aug       Impact factor: 5.715

Review 4.  Tumor hypoxia: its impact on cancer therapy.

Authors:  J E Moulder; S Rockwell
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

5.  High dose rate radiation treatment of experimental intramuscular prostate carcinoma.

Authors:  Christina Skourou; P Jack Hoopes; Summer L Gibbs-Strauss; David J Gladstone; Rendall Strawbridge; Keith D Paulsen
Journal:  Int J Radiat Biol       Date:  2009-04       Impact factor: 2.694

Review 6.  Bioreducible mustards: a paradigm for hypoxia-selective prodrugs of diffusible cytotoxins (HPDCs).

Authors:  W A Denny; W R Wilson
Journal:  Cancer Metastasis Rev       Date:  1993-06       Impact factor: 9.264

7.  Noninvasive multimodality imaging of the tumor microenvironment: registered dynamic magnetic resonance imaging and positron emission tomography studies of a preclinical tumor model of tumor hypoxia.

Authors:  HyungJoon Cho; Ellen Ackerstaff; Sean Carlin; Mihaela E Lupu; Ya Wang; Asif Rizwan; Joseph O'Donoghue; C Clifton Ling; John L Humm; Pat B Zanzonico; Jason A Koutcher
Journal:  Neoplasia       Date:  2009-03       Impact factor: 5.715

8.  The response of Dunning R3327 prostatic adenocarcinoma to IL-2, histamine and radiation.

Authors:  S Johansson; M Landström; K Hellstrand; R Henriksson
Journal:  Br J Cancer       Date:  1998-04       Impact factor: 7.640

9.  Non-invasive monitoring of photodynamic therapy with 99technetium HMPAO scintigraphy.

Authors:  R B Moore; J D Chapman; A D Mokrzanowski; M R Arnfield; M S McPhee; A J McEwan
Journal:  Br J Cancer       Date:  1992-04       Impact factor: 7.640

10.  A dual hypoxic marker technique for measuring oxygenation change within individual tumors.

Authors:  R V Iyer; E Kim; R F Schneider; J D Chapman
Journal:  Br J Cancer       Date:  1998-07       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.